These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9410066)

  • 21. In vitro activity of loracarbef against TEM extended-spectrum beta-lactamase-producing Escherichia coli strains and its interaction with the enzymes.
    Prinarakis EE; Tzouvelekis LS; Legakis NJ
    Chemotherapy; 1998; 44(4):260-4. PubMed ID: 9681202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
    Edwards JR
    New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.
    Blázquez J; Negri MC; Morosini MI; Gómez-Gómez JM; Baquero F
    Antimicrob Agents Chemother; 1998 May; 42(5):1042-4. PubMed ID: 9593123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unexpected enzyme TEM-126: role of mutation Asp179Glu.
    Delmas J; Robin F; Bittar F; Chanal C; Bonnet R
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4280-7. PubMed ID: 16189109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining an extended-spectrum beta-lactamase.
    Livermore DM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():3-10. PubMed ID: 18154524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae.
    Leblebicioglu H; Nas Y; Eroglu C; Sunbul M; Esen S; Gunaydin M
    J Chemother; 1999 Apr; 11(2):103-6. PubMed ID: 10326740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
    Beceiro A; Maharjan S; Gaulton T; Doumith M; Soares NC; Dhanji H; Warner M; Doyle M; Hickey M; Downie G; Bou G; Livermore DM; Woodford N
    J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Yagi T; Wachino J; Kurokawa H; Suzuki S; Yamane K; Doi Y; Shibata N; Kato H; Shibayama K; Arakawa Y
    J Clin Microbiol; 2005 Jun; 43(6):2551-8. PubMed ID: 15956362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia.
    Alyamani EJ; Khiyami AM; Booq RY; Majrashi MA; Bahwerth FS; Rechkina E
    Ann Clin Microbiol Antimicrob; 2017 Jan; 16(1):1. PubMed ID: 28061852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
    DeRyke CA; Banevicius MA; Fan HW; Nicolau DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1481-6. PubMed ID: 17283197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
    Poirel L; Mammeri H; Nordmann P
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4528-31. PubMed ID: 15561821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New mutations in ADC-type β-lactamases from Acinetobacter spp. affect cefoxitin and ceftazidime hydrolysis.
    Pérez A; Pérez-Llarena FJ; García P; Kerff F; Beceiro A; Galleni M; Bou G
    J Antimicrob Chemother; 2014 Sep; 69(9):2407-11. PubMed ID: 24845871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula.
    Maglio D; Ong C; Banevicius MA; Geng Q; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1941-7. PubMed ID: 15155182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Thomson KS; Moland ES
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3548-54. PubMed ID: 11709338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro activity of meropenem and seven other beta-lactam antibiotics against K.pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum].
    Cavallo JD; Fabre R; Crenn Y; Meyran M
    Pathol Biol (Paris); 1994 May; 42(5):365-8. PubMed ID: 7824297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
    Jang W; Park YJ; Park KG; Yu J
    J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.
    Brown NG; Pennington JM; Huang W; Ayvaz T; Palzkill T
    J Mol Biol; 2010 Dec; 404(5):832-46. PubMed ID: 20955714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations Utilize Dynamic Allostery to Confer Resistance in TEM-1 β-lactamase.
    Modi T; Ozkan SB
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unveiling the evolution routes of TEM-type extended-spectrum β-lactamases.
    Cheng Q; Cheung YC; Chan EWC; Wong KY; Chen S
    Int J Antimicrob Agents; 2022 Jan; 59(1):106498. PubMed ID: 34929294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.